Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort

por Cuzin, L, Allavena, C, Levy-Bachelot, L, Valantin, MA, Mellliez, H, Pugliese, P, Poizot-Martin, I, Duvivier, C, Finkielsztejn, L, Abel, S
Publicado 2010

Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up

por Seang, S., Itani, O., Monsel, G., Abdi, B., Marcelin, A.G., Valantin, M.A., Palich, R., Fayçal, A., Pourcher, V., Katlama, C., Tubiana, R.
Publicado 2022